Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Z-PYR-OH, also known as Carbobenzyloxy-L-pyroglutamic acid, is an amino acid derivative that serves as a crucial building block in the synthesis of various compounds. It is characterized by its white powder form and is widely utilized in the pharmaceutical and chemical industries due to its unique chemical properties.

32159-21-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 32159-21-0 Structure
  • Basic information

    1. Product Name: Z-PYR-OH
    2. Synonyms: n-cbz-l-pyroglutamicacidcrystalline;N-BENZYLOXYCARBONYL-L-PYROGLUTAMIC ACID;N-BENZYLOXYCARBONYL-L-PYRROLIDONE CARBOXYLIC ACID;N-CBZ-L-PYROGLUTAMIC ACID;N-ALPHA-CBZ-L-PYROGLUTAMIC ACID;N-ALPHA-CARBOBENZOXY-L-PYROGLUTAMIC ACID;(S)-5-OXO-PYRROLIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER;Z-PGLU-OH
    3. CAS NO:32159-21-0
    4. Molecular Formula: C13H13NO5
    5. Molecular Weight: 263.25
    6. EINECS: 250-936-0
    7. Product Categories: pharmacetical;Pyroglutamic acid [Pyr, pGu];Unusual Amino Acids;Z-Amino acid series;Amino Acids;I - Z;Modified Amino Acids
    8. Mol File: 32159-21-0.mol
  • Chemical Properties

    1. Melting Point: 128-130°C
    2. Boiling Point: 525.4 °C at 760 mmHg
    3. Flash Point: 271.5 °C
    4. Appearance: /
    5. Density: 1.408 g/cm3
    6. Vapor Pressure: 7.26E-12mmHg at 25°C
    7. Refractive Index: 1.597
    8. Storage Temp.: −20°C
    9. Solubility: DMSO (Slightly), Methanol (Sparingly)
    10. PKA: 3.03±0.20(Predicted)
    11. CAS DataBase Reference: Z-PYR-OH(CAS DataBase Reference)
    12. NIST Chemistry Reference: Z-PYR-OH(32159-21-0)
    13. EPA Substance Registry System: Z-PYR-OH(32159-21-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: 22/22-36/37/38
    3. Safety Statements: 22-24/25-44-35-28-7-4
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 32159-21-0(Hazardous Substances Data)

32159-21-0 Usage

Uses

Used in Pharmaceutical Industry:
Z-PYR-OH is used as an amino acid building block for the synthesis of various compounds, such as 5-Oxo-L-prolyl-L-proline (O859055). Its role in the creation of these compounds is essential for the development of new drugs and therapeutic agents.
Used in Chemical Industry:
In the chemical industry, Z-PYR-OH is utilized as a key component in the synthesis of complex molecules and organic compounds. Its unique properties make it a valuable asset in the development of new materials and chemical processes.
Used in Research and Development:
Z-PYR-OH is also employed in research and development settings, where it is used to study the properties and behavior of amino acid derivatives. This helps scientists and researchers gain a deeper understanding of the molecular structures and interactions that are crucial for the advancement of various scientific fields.

Check Digit Verification of cas no

The CAS Registry Mumber 32159-21-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,1,5 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 32159-21:
(7*3)+(6*2)+(5*1)+(4*5)+(3*9)+(2*2)+(1*1)=90
90 % 10 = 0
So 32159-21-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H13NO5/c15-11-7-6-10(12(16)17)14(11)13(18)19-8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,16,17)/t10-/m0/s1

32159-21-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C3143)  N-Carbobenzoxy-L-pyroglutamic Acid  >98.0%(HPLC)(T)

  • 32159-21-0

  • 5g

  • 590.00CNY

  • Detail
  • TCI America

  • (C3143)  N-Carbobenzoxy-L-pyroglutamic Acid  >98.0%(HPLC)(T)

  • 32159-21-0

  • 25g

  • 2,100.00CNY

  • Detail
  • Alfa Aesar

  • (H62886)  (S)-1-Benzyloxycarbonyl-5-oxopyrrolidine-2-carboxylic acid, 98%   

  • 32159-21-0

  • 5g

  • 546.0CNY

  • Detail
  • Alfa Aesar

  • (H62886)  (S)-1-Benzyloxycarbonyl-5-oxopyrrolidine-2-carboxylic acid, 98%   

  • 32159-21-0

  • 25g

  • 2185.0CNY

  • Detail

32159-21-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-5-oxo-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names Z-L-pyroglutamic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:32159-21-0 SDS

32159-21-0Synthetic route

sodium carbonate
497-19-8

sodium carbonate

benzyl chloroformate
501-53-1

benzyl chloroformate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
In 1,4-dioxane; sodium hydroxide87%
benzyl chloroformate
501-53-1

benzyl chloroformate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
With triethylamine In acetonitrile for 1h; Ambient temperature;20%
With 2,2,2-trifluoro-N,N-bis(trimethylsilyl)-acetamide; acetonitrile; methyloxirane 1.) r.t., 15 min, 2.) 1 h; Yield given. Multistep reaction;
N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
With N-cyclohexyl-cyclohexanamine; dicyclohexyl-carbodiimide 1.) THF, 0 deg C; Multistep reaction;
Yield given. Multistep reaction;
Multi-step reaction with 2 steps
1: DCC / tetrahydrofuran / 0 °C
2: dicyclohexylamine (DCHA) / tetrahydrofuran / 0 °C
View Scheme
N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
With N-cyclohexyl-cyclohexanamine In tetrahydrofuran at 0℃; Yield given;
2-bromothiophene
1003-09-4

2-bromothiophene

N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

A

(S)-4-Benzyloxycarbonylamino-5-oxo-5-thiophen-2-yl-pentanoic acid

(S)-4-Benzyloxycarbonylamino-5-oxo-5-thiophen-2-yl-pentanoic acid

B

N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

C

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
Stage #1: 2-bromothiophene With magnesium In tetrahydrofuran at 40℃; for 2h;
Stage #2: N-(benzyloxycarbonyl)-L-glutamic acid anhydride In tetrahydrofuran at -78℃; for 4h;
Stage #3: With citric acid In tetrahydrofuran at -78 - 20℃; Title compound not separated from byproducts;
1-bromo-butane
109-65-9

1-bromo-butane

N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

A

(S)-4-Benzyloxycarbonylamino-5-oxo-nonanoic acid

(S)-4-Benzyloxycarbonylamino-5-oxo-nonanoic acid

B

N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

C

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
Stage #1: 1-bromo-butane With magnesium In tetrahydrofuran at 40℃; for 2h;
Stage #2: N-(benzyloxycarbonyl)-L-glutamic acid anhydride In tetrahydrofuran at -78℃; for 4h;
Stage #3: With citric acid In tetrahydrofuran at -78 - 20℃; Title compound not separated from byproducts;
3-methoxyphenyl bromide
2398-37-0

3-methoxyphenyl bromide

N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

A

(S)-4-Benzyloxycarbonylamino-5-(3-methoxy-phenyl)-5-oxo-pentanoic acid

(S)-4-Benzyloxycarbonylamino-5-(3-methoxy-phenyl)-5-oxo-pentanoic acid

B

N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

C

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
Stage #1: 3-methoxyphenyl bromide With magnesium In tetrahydrofuran at 40℃; for 2h;
Stage #2: N-(benzyloxycarbonyl)-L-glutamic acid anhydride In tetrahydrofuran at -78℃; for 4h;
Stage #3: With citric acid In tetrahydrofuran at -78 - 20℃; Title compound not separated from byproducts;
1-bromo-hexane
111-25-1

1-bromo-hexane

N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

A

(S)-4-Benzyloxycarbonylamino-5-oxo-undecanoic acid

(S)-4-Benzyloxycarbonylamino-5-oxo-undecanoic acid

B

N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

C

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
Stage #1: 1-bromo-hexane With magnesium In tetrahydrofuran at 40℃; for 2h;
Stage #2: N-(benzyloxycarbonyl)-L-glutamic acid anhydride In tetrahydrofuran at -78℃; for 4h;
Stage #3: With citric acid In tetrahydrofuran at -78 - 20℃; Title compound not separated from byproducts;
phenylmagnesium chloride
100-59-4

phenylmagnesium chloride

N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

A

(S)-4-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

(S)-4-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

B

N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

C

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
Stage #1: phenylmagnesium chloride; N-(benzyloxycarbonyl)-L-glutamic acid anhydride In tetrahydrofuran at -78℃; for 4h;
Stage #2: With citric acid In tetrahydrofuran
phenyllithium
591-51-5

phenyllithium

N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

A

(S)-2-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

(S)-2-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

B

(S)-4-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

(S)-4-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

C

N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

D

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
Stage #1: phenyllithium; N-(benzyloxycarbonyl)-L-glutamic acid anhydride In tetrahydrofuran at -78℃; for 4h;
Stage #2: With citric acid In tetrahydrofuran
N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

A

N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

B

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
Stage #1: N-(benzyloxycarbonyl)-L-glutamic acid anhydride With tert-butylmagnesium chloride In tetrahydrofuran at -78℃; for 4h;
Stage #2: With citric acid In tetrahydrofuran
Stage #1: N-(benzyloxycarbonyl)-L-glutamic acid anhydride With phenylzinc chloride In tetrahydrofuran at -78℃; for 2h;
Stage #2: With citric acid In tetrahydrofuran
N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

Ph3MgLi

Ph3MgLi

A

(S)-2-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

(S)-2-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

B

(S)-4-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

(S)-4-Benzyloxycarbonylamino-5-oxo-5-phenyl-pentanoic acid

C

N-benzyloxycarbonyl-L-glutamic acid
1155-62-0

N-benzyloxycarbonyl-L-glutamic acid

D

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Conditions
ConditionsYield
Stage #1: N-(benzyloxycarbonyl)-L-glutamic acid anhydride; Ph3MgLi In tetrahydrofuran at -78 - 20℃;
Stage #2: With citric acid In tetrahydrofuran
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

methyl iodide
74-88-4

methyl iodide

(5S)-N-(benzyloxycarbonyl)-5-methoxycarbonyl-2-pyrrolidinone
75857-94-2

(5S)-N-(benzyloxycarbonyl)-5-methoxycarbonyl-2-pyrrolidinone

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane98%
With N-ethyl-N,N-diisopropylamine In dichloromethane for 6.5h; Heating / reflux;98%
(2R,4'R,8'R)-α-tocopheramine
3398-70-7

(2R,4'R,8'R)-α-tocopheramine

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

A

vitamin E amine pyroglutamate conjugate

vitamin E amine pyroglutamate conjugate

B

N-methylmorpholine hydrochloride
3651-67-0

N-methylmorpholine hydrochloride

Conditions
ConditionsYield
Stage #1: Cbz-L-pGlu-OH With 4-methyl-morpholine; isobutyl chloroformate In tetrahydrofuran at 0 - 20℃; for 2h;
Stage #2: (2R,4'R,8'R)-α-tocopheramine With triethylamine In tetrahydrofuran at 0℃;
A 98%
B n/a
VESA-PEG-NH2

VESA-PEG-NH2

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

A

Reaxys ID: 11380187

Reaxys ID: 11380187

B

N-methylmorpholine hydrochloride
3651-67-0

N-methylmorpholine hydrochloride

Conditions
ConditionsYield
Stage #1: Cbz-L-pGlu-OH With 4-methyl-morpholine; isobutyl chloroformate In tetrahydrofuran at 0 - 20℃; for 2h;
Stage #2: VESA-PEG-NH2 With triethylamine In tetrahydrofuran; water at 0℃;
A 98%
B n/a
tryptamine
61-54-1

tryptamine

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

(S)-2-[2-(1H-Indol-3-yl)-ethylcarbamoyl]-5-oxo-pyrrolidine-1-carboxylic acid benzyl ester

(S)-2-[2-(1H-Indol-3-yl)-ethylcarbamoyl]-5-oxo-pyrrolidine-1-carboxylic acid benzyl ester

Conditions
ConditionsYield
In tetrahydrofuran Heating;90%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

benzyl chloride
100-44-7

benzyl chloride

dibenzyl (2S)-5-oxotetrahydro-1H-pyrrole-1,2-dicarboxylate
71389-33-8

dibenzyl (2S)-5-oxotetrahydro-1H-pyrrole-1,2-dicarboxylate

Conditions
ConditionsYield
With triethylamine In acetone for 72h; Heating;85%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Z-Glp-NH2

Z-Glp-NH2

Conditions
ConditionsYield
With pyridine; di-tert-butyl dicarbonate; ammonium bicarbonate In 1,4-dioxane 4-16 h;84%
1,2,3-Benzotriazole
95-14-7

1,2,3-Benzotriazole

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

benzyl (2S)-2-(1H-1,2,3-benzotriazol-1-ylcarbonyl)-5-oxotetrahydro-1H-pyrrole-1-carboxylate
958637-27-9

benzyl (2S)-2-(1H-1,2,3-benzotriazol-1-ylcarbonyl)-5-oxotetrahydro-1H-pyrrole-1-carboxylate

Conditions
ConditionsYield
Stage #1: 1,2,3-Benzotriazole With thionyl chloride In dichloromethane at 40 - 50℃; for 0.333333h;
Stage #2: Cbz-L-pGlu-OH In dichloromethane at 20℃; for 2h; Further stages.;
84%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

tert-butyl N-benzyloxycarbonyl-L-pyroglutamate
81470-51-1

tert-butyl N-benzyloxycarbonyl-L-pyroglutamate

Conditions
ConditionsYield
With perchloric acid In water at 20℃; for 16h;79%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

N-methyl-m-toluidine
696-44-6

N-methyl-m-toluidine

benzyl (2S)-2-[methyl(m-tolyl)carbamoyl]-5-oxopyrrolidine-1-carboxylate

benzyl (2S)-2-[methyl(m-tolyl)carbamoyl]-5-oxopyrrolidine-1-carboxylate

Conditions
ConditionsYield
With pyridine; 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In ethyl acetate at 20℃; for 12h;75%
8-amino quinoline
578-66-5

8-amino quinoline

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

C22H19N3O4

C22H19N3O4

Conditions
ConditionsYield
Stage #1: Cbz-L-pGlu-OH With chloroformic acid ethyl ester; triethylamine In tetrahydrofuran at 0 - 20℃; for 1.5h;
Stage #2: 8-amino quinoline In tetrahydrofuran at 20℃; for 6h;
74%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

4-methoxy-aniline
104-94-9

4-methoxy-aniline

(S)-2-(4-Methoxy-phenylcarbamoyl)-5-oxo-pyrrolidine-1-carboxylic acid benzyl ester
339994-37-5

(S)-2-(4-Methoxy-phenylcarbamoyl)-5-oxo-pyrrolidine-1-carboxylic acid benzyl ester

Conditions
ConditionsYield
With 4-methyl-morpholine; chloroformic acid ethyl ester In ethyl acetate at -15 - 20℃; for 50h;68%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Ala2-PheCH3, HBr
90427-75-1

Ala2-PheCH3, HBr

Z-Glp-Ala2-PheCH3
88576-78-7

Z-Glp-Ala2-PheCH3

Conditions
ConditionsYield
With chloroformic acid ethyl ester; triethylamine In tetrahydrofuran67%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

isobutene
115-11-7

isobutene

tert-butyl N-benzyloxycarbonyl-L-pyroglutamate
81470-51-1

tert-butyl N-benzyloxycarbonyl-L-pyroglutamate

Conditions
ConditionsYield
With sulfuric acid In dichloromethane67%
Stage #1: Cbz-L-pGlu-OH; isobutene With sulfuric acid In dichloromethane at 20℃; Cooling with ice;
Stage #2: With sodium carbonate In dichloromethane; water
67%
With sulfuric acid In dichloromethane at 20℃; Cooling with ice;67%
With sulfuric acid In dichloromethane at 20℃; Cooling with ice;67%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

L-glutamic acid dibenzyl ester 4-toluenesulfonate
2791-84-6

L-glutamic acid dibenzyl ester 4-toluenesulfonate

Z-pGlu-Glu(OBzl)-OBzl
122389-55-3

Z-pGlu-Glu(OBzl)-OBzl

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane63%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

benzyl (2S)-2-(hydroxymethyl)-5-oxopyrrolidine-1-carboxylate
153870-19-0

benzyl (2S)-2-(hydroxymethyl)-5-oxopyrrolidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: Cbz-L-pGlu-OH With 4-methyl-morpholine; chloroformic acid ethyl ester In tetrahydrofuran at -10℃;
Stage #2: With sodium tetrahydroborate In methanol at 0℃;
61%
Multi-step reaction with 2 steps
1: N-methyl morpholine / tetrahydrofuran / 0.08 h / -5 °C
2: NaBH4 / tetrahydrofuran
View Scheme
L-histidine methyl ester
95384-14-8

L-histidine methyl ester

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

N-Z-L-pyroglutamyl-L-histidine methyl ester

N-Z-L-pyroglutamyl-L-histidine methyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In N,N-dimethyl-formamide; acetonitrile 1h at -10 deg C, then 12h at 4 deg C;55%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

benzyl bromide
100-39-0

benzyl bromide

dibenzyl (2S)-5-oxotetrahydro-1H-pyrrole-1,2-dicarboxylate
71389-33-8

dibenzyl (2S)-5-oxotetrahydro-1H-pyrrole-1,2-dicarboxylate

Conditions
ConditionsYield
With potassium hydrogencarbonate In N,N-dimethyl-formamide for 18h; Ambient temperature;51%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

3-chloro-benzenecarboperoxoic acid
937-14-4

3-chloro-benzenecarboperoxoic acid

(R)-2-(3-Chloro-benzoyloxy)-5-oxo-pyrrolidine-1-carboxylic acid benzyl ester
130654-55-6

(R)-2-(3-Chloro-benzoyloxy)-5-oxo-pyrrolidine-1-carboxylic acid benzyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In chloroform at 25℃; for 1h;42%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Ala3-PheCH3, HBr
90427-76-2

Ala3-PheCH3, HBr

Z-Glp-Ala3-PheCH3
88576-80-1

Z-Glp-Ala3-PheCH3

Conditions
ConditionsYield
With chloroformic acid ethyl ester; triethylamine In tetrahydrofuran40%
BOC-glycine
4530-20-5

BOC-glycine

L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

N-Boc-O-benzyl-L-threonine
15260-10-3

N-Boc-O-benzyl-L-threonine

Boc-Arg(Tos)-OH
13836-37-8

Boc-Arg(Tos)-OH

BOC-O-benzyl-L-serine
23680-31-1

BOC-O-benzyl-L-serine

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

Boc-Asp(O-cyclohexyl)-OH
73821-95-1

Boc-Asp(O-cyclohexyl)-OH

Boc-cysteine(4-Me-Bn)
61925-77-7

Boc-cysteine(4-Me-Bn)

Boc-(S)-Lys(2-Cl-Z)-OH
54613-99-9

Boc-(S)-Lys(2-Cl-Z)-OH

Nα-tert-butoxycarbonyl-1-formyl-L-tryptophan
47355-10-2

Nα-tert-butoxycarbonyl-1-formyl-L-tryptophan

N(α)-t-butoxycarbonyl-N(ϖ)-benzyloxymethyl-L-histidine
83468-83-1

N(α)-t-butoxycarbonyl-N(ϖ)-benzyloxymethyl-L-histidine

rerdused μ-conotoxin SIIIA

rerdused μ-conotoxin SIIIA

Conditions
ConditionsYield
Stage #1: Boc-cysteine(4-Me-Bn) With benzotriazol-1-ol In 1-methyl-pyrrolidin-2-one Automated synthesizer;
Stage #2: With trifluoroacetic acid
Stage #3: BOC-glycine; L-N-Boc-Ala; N-Boc-O-benzyl-L-threonine; Boc-Arg(Tos)-OH; BOC-O-benzyl-L-serine; Cbz-L-pGlu-OH; Boc-Asp(O-cyclohexyl)-OH; Boc-cysteine(4-Me-Bn); Boc-(S)-Lys(2-Cl-Z)-OH; Nα-tert-butoxycarbonyl-1-formyl-L-tryptophan; N(α)-t-butoxycarbonyl-N(ϖ)-benzyloxymethyl-L-histidine
22%
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

N-benzyloxycarbonyl-L-glutamic acid-5-hydrazide
4510-09-2

N-benzyloxycarbonyl-L-glutamic acid-5-hydrazide

Conditions
ConditionsYield
With hydrazine hydrate
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

benzylamine
100-46-9

benzylamine

N'-benzyl-N-benzyloxycarbonyl-L-glutamine
64153-27-1

N'-benzyl-N-benzyloxycarbonyl-L-glutamine

acetic acid tert-butyl ester
540-88-5

acetic acid tert-butyl ester

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

tert-butyl N-benzyloxycarbonyl-L-pyroglutamate
81470-51-1

tert-butyl N-benzyloxycarbonyl-L-pyroglutamate

Conditions
ConditionsYield
With perchloric acid Yield given. Multistep reaction;
With perchloric acid Ambient temperature; Yield given;
diethyl 1-aminoethylphosphonate
54788-35-1

diethyl 1-aminoethylphosphonate

Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

(S)-2-[1-(Diethoxy-phosphoryl)-ethylcarbamoyl]-5-oxo-pyrrolidine-1-carboxylic acid benzyl ester

(S)-2-[1-(Diethoxy-phosphoryl)-ethylcarbamoyl]-5-oxo-pyrrolidine-1-carboxylic acid benzyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 6.5h;
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

L-tryptophan ethyl ester hydrochloride
2899-28-7, 6519-67-1, 61535-49-7, 67557-18-0, 68401-14-9

L-tryptophan ethyl ester hydrochloride

N-carbobenzoxy-L-pyroglutamyl-L-tryptophan ethyl ester
87694-59-5

N-carbobenzoxy-L-pyroglutamyl-L-tryptophan ethyl ester

Conditions
ConditionsYield
With chloroformic acid ethyl ester; triethylamine 1.) THF, 0 deg C, 30 min, 2.) r.t., 3 h; Yield given. Multistep reaction;
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

tert.-butyloxycarbonylalanyl-Nε-benzyloxycarbonyllysyl-serine methyl ester
84983-67-5

tert.-butyloxycarbonylalanyl-Nε-benzyloxycarbonyllysyl-serine methyl ester

Z-Pyr-Ala-Lys(Z)-Ser-OMe
84983-68-6

Z-Pyr-Ala-Lys(Z)-Ser-OMe

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; methoxybenzene; trifluoroacetic acid 1.) room temperature, 20 min 2.) DMF, 0 deg C, overnight, 4 deg C; Yield given. Multistep reaction;
Cbz-L-pGlu-OH
32159-21-0

Cbz-L-pGlu-OH

HCl.H-Leu-Gly-NH2
38173-66-9

HCl.H-Leu-Gly-NH2

(Z)--Leu-Gly-NH2
39705-62-9

(Z)--Leu-Gly-NH2

Conditions
ConditionsYield
With 4-methyl-morpholine; triethylamine; isobutyl chloroformate 1.) THF, -20 deg C, 10 min, 2.) THF, DMF, H2O, RT, 1 h; Yield given. Multistep reaction;

32159-21-0Relevant articles and documents

Selective Electrochemical Oxidation of Functionalized Pyrrolidines

Deprez, Nicholas R.,Clausen, Dane J.,Yan, Jia-Xuan,Peng, Feng,Zhang, Shaoguang,Kong, Jongrock,Bai, Yanguang

supporting information, p. 8834 - 8837 (2021/11/20)

A method for the selective electrochemical aminoxyl-mediated Shono-type oxidation of pyrrolidines to pyrrolidinones is described. These transformations show the high selectivity and functional group compatibility. This chemistry also demonstrates the use of an operationally simple ElectraSyn 2.0 and cost-effective stainless-steel electrode for the electrochemical oxidation of functionalized pyrrolidines.

Preparation method of (S)-1 - (benzyloxycarbonyl) -5 -oxo-pyrrolidine -2 - formic acid

-

Paragraph 0014; 0017-0018; 0021-0022; 0025-0026; 0029-00..., (2021/09/01)

The invention discloses a preparation method of (S)-1 - (benzyloxycarbonyl) -5 -oxo-pyrrolidine -2 - formic acid, which mainly solves the complexity in the original process, and is long in period and high in cost. The method specifically comprises first steps of preparing L - benzyloxycarbonyl N - glutamic acid from - L - glutamic acid and a benzyloxycarbonyl donor, second steps of intramolecular condensation cyclization N - benzyloxycarbonyl - L - glutamic acid to obtain the N -benzyloxycarbonyl - L - glutamic acid crude product. The third The crude N - benzyloxycarbonyl - L - glutamic acid crude product and the organic amine base are mixed, and the organic amine salt form is prepared by the solubility of the product in a solvent, fourth (N -) - L - (benzyloxycarbonyl) S oxopyrrolidine -1 - formic acid is prepared by desalinating -5 - benzyloxycarbonyl -2 - glutamic acid. To the method, the high-purity product is prepared, and the yield and the quality are greatly improved.

Regioselective opening of N-Cbz glutamic and aspartic anhydrides with carbon nucleophiles

Deguest, Geoffrey,Bischoff, Laurent,Fruit, Corinne,Marsais, Francis

, p. 2120 - 2125 (2007/10/03)

Depending on the experimental conditions, aspartic and glutamic anhydrides can be opened regioselectively with Grignard reagents, thus giving access to different isomers of chiral amino-ketoesters.

Semi-synthetic alanyl didemnin analogs

-

, (2008/06/13)

The didemnin class of biologically active cyclodepsipeptides, isolated from the marine tunicate Trididemnun solidum, has shown considerable antitumor, antiviral, and immunosuppressive activities. Didemnin B (DB) and most other natural didemnins contain a common macrocycle and differ only in the composition of the side chain. In the present invention, structural modifications were introduced in the side chain to afford several didemnin analogues for structure-activity relationship studies. The latter have shown that the linear side chain portion of the didemnin core structure can be altered and, in some cases, provide significant gains in bioactivities. Of the compounds synthesized the new [Ala9] didemnin B is the most active against the L1210 (murine leukemia) cell line, at the 0.04 ng/mL level.

Synthesis, characterization and in vitro hydrolysis of L-pyroglutamyl-L-tryptophan derivatives as potential drug carriers

Bousquet,De Regis,Giannola,Santagati,Tirendi

, p. 260 - 262 (2007/10/02)

The condensation reaction of L-tryptophan with L-pyroglutamic acid or its N-carbobenzyloxy derivative in the presence of dicyclohexylcarbodiimide (DCC) afforded dipeptide molecules identified as L-pyroglutamyl-L-tryptophan derivatives. The synthesized dipeptide molecules offer a potentially useful means to obtain drug carriers and improve the poor uptake of drug molecules to the brain. The chemical hydrolysis characteristics in simulated gastro-intestinal juices are reported. No significant hydrolysis was observed.

Synthesis and Siderophore Activity of Albomycin-like Peptides Derived from N5-Acetyl-N5-hydroxy-L-ornithine

Dolence, E. Kurt,Lin, Chia-En,Miller, Marvin J.,Payne, Shelley M.

, p. 956 - 968 (2007/10/02)

N5-Acetyl-N5-hydroxy-L-ornithine (1), the key constituent of several microbial siderophores, has been synthesized in 23percent yield overall from N-Cbz-L-glutamic acid 1-tert-butyl ester (6) derived from L-glutamic acid.Reduction of 6 to 7 and treatment with N-(trichloroethoxy)carbonyl>-O-benzylhydroxylamine (8), and diethyl azodicarboxylate and triphenylphosphine followed by deprotection produced the protected N5-acetyl-N5-hydroxy-L-ornithine derivatives 11 and 12 in large quantities (10-20 g).Following α-amino and α-carboxyl deprotections of 11 and 12, EEDQ mediated peptide coupling and final deprotection provided amino acid 1 and six albomycin-like peptides (20, 23, 25, 28, 35, and 36).The growth-promoting ability of each was evaluated with the siderophore biosynthesis mutant Shigella flexneri SA240 (SA 100 iucD:Tn5).These results indicate that substantial modification of the framework of peptide-based siderophores can be tolerated by microbial iron-transport systems.

Amino Acid Synthesis Using (L)-Pyroglutamic Acid as a Chiral Starting Material

Baldwin, Jack E.,Miranda, Tania,Moloney, Mark,Hokelek, Tuncer

, p. 7459 - 7468 (2007/10/02)

Deprotonation of protected pyroglutamates 1(c), 1(d), and 1(e) with lithium di-isopropylamine (LDA) or lithium hexamethyldisilazide (LiHDMS) in THF, followed by reaction with electrophiles, leads to the formation of 4-substituted pyroglutamates in good yield.This approach has been used for the synthesis of the novel amino acid (4).Key Words: pyroglutamic acid; chiral amino acid synthesis

A Convenient Preparation of N-Acylpyroglutamic Acid

Imaki, Katsuhiro,Niwa, Haruki,Sakuyama, Shigeru,Okada, Takanori,Toda, Masaaki,Hayashi, Masaki

, p. 2699 - 2701 (2007/10/02)

Pyroglutamic acid reacted with acyl chloride in the presence of triethylamine in acetonitrile, yielding N-acylpyroglutamic acid without epimerization by way of mixed anhydride formation followed by intramolecular N-acylation.Keywords - angiotensin-converting enzyme; pyroglutamic acid; N-acylpyroglutamic acid; (2S)-1-pyroglutamic acid; N-acetyl-L-pyroglutamic acid

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 32159-21-0